Keyword Suggestion
Domain Informations
Sandostatin.com lookup results from whois.markmonitor.com server:
- Domain created: 1997-09-02T04:00:00Z
- Domain updated: 2024-07-31T09:02:41Z
- Domain expires: 2026-09-01T04:00:00Z 0 Years, 255 Days left
- Website age: 28 Years, 108 Days
- Registrar Domain ID: 448955_DOMAIN_COM-VRSN
- Registrar Url: http://www.markmonitor.com
- Registrar WHOIS Server: whois.markmonitor.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +1.2086851750
- Name server:
- A1-254.AKAM.NET
- A2-66.AKAM.NET
- A24-65.AKAM.NET
- A28-67.AKAM.NET
- A7-64.AKAM.NET
- A9-65.AKAM.NET
- DNS1.NOVARTIS.COM
- DNS2.NOVARTIS.COM
- DNS3.NOVARTIS.COM
- DNS4.NOVARTIS.COM
Network
- inetnum : 104.16.0.0 - 104.31.255.255
- name : CLOUDFLARENET
- handle : NET-104-16-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2024-11-25
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse,Geofeed: https://api.cloudflare.com/local-ip-ranges.csv
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 104.18.29.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 104.18.29.10)
Spam Check (IP: 104.18.29.10)
Recent Searched Sites
› Kdh.co.nz (8 seconds ago) / US
› Libmma.s3.amazonaws.com (4 seconds ago) / US
› Bblutheran.com (14 seconds ago) / US
› Waffles-menu.com (15 seconds ago) / US
› Transformcambodia.com (2 seconds ago) / AU
› Profile.planyourtrip.travel (4 seconds ago) / US
› Westlakehs-ar.rschooltoday.com (11 seconds ago) / US
› Whogoblog.com (3 seconds ago) / US
› Calsomahsdge.powerclerk.com (5 seconds ago) / US
› Higgins-horton-3.technetbloggers.de (13 seconds ago) / US
› Alyssasundale.fanbox.cc (7 seconds ago) / US
› Ep-university.net (9 seconds ago) / JP
› Ch.etopup.vodafoneidea.com (0 seconds ago) / NL
› Imsxpload.aplusvod.com (2 seconds ago) / US
› Aigrid.cn (2 seconds ago) / JP
› Honnassiri.in (5 seconds ago) / US
› Sandostatin.com (0 seconds ago) / US
› Arcsanengraving.com (1 seconds ago) / US
› Aemprodtest.thelandinggroup.ca (3 seconds ago) / CA
› Estudante.sptrans.com.br (5 seconds ago) / US
Websites Listing
We found Websites Listing below when search with sandostatin.com on Search Engine
SANDOSTATIN® LAR Depot (octreotide acetate) for Acromegaly ...
Approved Use. Sandostatin ® LAR Depot (octreotide acetate) for injectable suspension is indicated for patients in whom initial treatment with immediate-release Sandostatin ® (octreotide acetate) Injection has been shown to be effective and tolerated for. Long-term maintenance therapy in acromegalic patients who have had inadequate response to surgery and/or …
Us.sandostatin.comSandostatin LAR Depot (octreotide acetate for injectable ...
Fill out Sandostatin LAR Depot Co-Pay Card Information 3. Read Terms and Conditions on page 2 4. Complete and sign Certification Statement 5. Mail, email, submit online, or fax this form along with the items listed on page 2 of this form STEP Patient Information (please print) Last Name: First Name: Address 1: ddress 2: A City: State: ZIP: Date of Birth: / / Phone #: ( ) - Email: …
Us.sandostatin.comThe Sandostatin® LAR® Mobile Administration Program
Mobile Administration Program *. Novartis’ Mobile Administration Program (MAP) was created to provide patients with access to receive Sandostatin ® LAR ® at a time and place of their choosing, making it more convenient, comfortable, and cost-effective than traveling to a medical facility. Mobile administration can also give you the confidence and peace of mind that …
Sandostatin.comSandostatin LAR Depot
Sandostatin® (octreotide acetate) Injection with the added feature of slow release of octreotide from the site of injection, reducing the need for frequent administration. This slow release occurs as the polymer biodegrades, primarily through hydrolysis. Sandostatin LAR® Depot is designed to be injected intramuscularly (intragluteally) once
Accessdata.fda.govSandostatin: Uses, side effects, dosage, how to use, and more
2020-08-20 · Sandostatin (octreotide acetate) is a prescription injection for acromegaly, carcinoid tumor symptoms, and more. Learn about uses, side effects, and more.
Medicalnewstoday.comSandostatin (oktreotyd) roztwór do wstrzykiwań lub infuzji ...
Sandostatin nie jest lekiem przeciwnowotworowym i nie powoduje u tych pacjentów wyleczenia. Zapobieganie powikłaniom po operacjach trzustki. Nagłe postępowanie w celu zahamowania krwawień lub zapobiegania nawrotom krwawień z żylaków żołądkowo-przełykowych w przebiegu marskości wątroby. Produkt leczniczy Sandostatin jest stosowany w połączeniu ze …
Mp.plSandostatin LAR - Summary of Product Characteristics (SmPC ...
2021-11-16 · SmPC. This information is intended for use by health professionals. 1. Name of the medicinal product. Sandostatin ® LAR ® 10 mg, 20mg or 30mg powder and solvent for suspension for injection. 2. Qualitative and quantitative composition. One vial contains 10 mg, 20mg or 30mg octreotide (as octreotide acetate).
Medicines.org.ukDilution Octreotide -Sandostatin ® - GlobalRPH
2017-09-03 · Sandostatin® (octreotide acetate) may be administered subcutaneously or intravenously. Subcutaneous injection is the usual route of administration of Sandostatin for control of symptoms. Pain with subcutaneous administration may be reduced by using the smallest volume that will deliver the desired dose. Multiple subcutaneous injections at the …
Globalrph.comHIGHLIGHTS OF PRESCRIBING INFORMATION ...
SANDOSTATIN LAR DEPOT dosage to 30 mg every 4 weeks • GH ≤1 ng/mL, IGF-1 normal, and clinical symptoms controlled, reduce SANDOSTATIN LAR DEPOT dosage to 10 mg every 4 weeks • If GH, IGF-1, or symptoms are not adequately controlled at a dose of 30 mg, the dose may be increased to 40 mg every 4 weeks. Doses higher than 40 mg are not recommended. …
Accessdata.fda.govSANDOSTATIN injektio-/infuusioneste, liuos 50 mikrog/ml ...
2021-07-23 · Sandostatin 500 mikrog/ml, injektio-/infuusioneste, liuos. oktreotidi. Yleisiä ohjeita. Lue tämä pakkausseloste huolellisesti ennen kuin aloitat lääkkeen käyttämisen, sillä se sisältää sinulle tärkeitä tietoja. Säilytä tämä pakkausseloste. Voit tarvita sitä myöhemmin. Jos sinulla on kysyttävää, käänny lääkärin, apteekkihenkilökunnan tai sairaanhoitajan puoleen ...
Laakeinfo.fiOCTREOTIDE IN GASTROENTEROLOGY
2017-06-26 · Octreotide is an octapeptide in which the four amino acid sequence essential for the biological activity of the native hormone is retained. However, incorporation of N-phenylalaninc, L-terminal amino alcohol, D-trytophan and a cysteine bridge makes the molecule very resistant to metabolic degradation . The increased resistance of octreotide to metabolic …
Ncbi.nlm.nih.govPríbalový leták SANDOSTATIN 500 mcg/1 ml - ADC.sk
SANDOSTATIN 100 mikrogamov/1 ml injekčný/infúzny roztok . SANDOSTATIN 500 mikrogamov/1 ml injekčný/infúzny roztok . oktreotid. Pozorne si prečítajte celú písomnú informáciu predtým, ako začnete používať tento liek, pretože obsahuje pre vás dôležité informácie. Túto písomnú informáciu si uschovajte. Možno bude potrebné, aby ste si ju znovu prečítali. Ak máte ...
Adc.skSandostatin, Sandostatin LAR (octreotide) dosing ...
By decreasing watery diarrhea, octreotide helps to reduce the loss of body fluids and minerals.Octreotide is also used to treat a certain condition (acromegaly) that occurs when the body makes too much of a certain natural substance called growth hormone. Treating acromegaly helps reduce the risk of serious problems such as diabetes and heart disease. Octreotide …
Reference.medscape.comSandostatin® - information til sundhedsfaglige - Medicin.dk
Sandostatin® Revisionsdato 12.10.2021. Priserne er dog gældende pr. mandag den 27. december 2021 ...
Pro.medicin.dkSandostatin Market Research Overview 2021-2026 : Industry ...
2021-12-09 · Sandostatin Market Growth (Status and Outlook) 2021-2026 : The increasing use of Sandostatin in Tumors, Bleeding Esophageal Varices and other industries is driving the growth of the Sandostatin ...
Marketwatch.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| caresnw.org | networksolutions.com | -3 Years, -184 Days |
| meijutt.org | namebright.com | -2 Years, -298 Days |
| biomedsa.org | ionos.com | -3 Years, -57 Days |
| semanticsevolution.com | godaddy.com | -1 Years, -356 Days |
| masterfincorp.com | godaddy.com | 37 Days |
| likeretro.com | realtimeregister.com | -3 Years, -148 Days |
| panoston.com | networksolutions.com | -3 Years, -76 Days |
| unpaper.com | domains.google.com | -3 Years, -189 Days |
| rothomypet.com | key-systems.net | -3 Years, -316 Days |
| redfoxden.org | dreamhost.com | -3 Years, -103 Days |